BrainStorm Cell Therapeutics
BCLI
#10103
Rank
โ‚ฌ6.39 M
Marketcap
0,98ย โ‚ฌ
Share price
14.87%
Change (1 day)
-87.04%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -0,56ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -0,52ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,58ย โ‚ฌ an increase over its 2021 EPS that were of -0,60ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,56ย โ‚ฌ-2.62%
2022-0,58ย โ‚ฌ-2.94%
2021-0,60ย โ‚ฌ-37.04%
2020-0,95ย โ‚ฌ1.89%
2019-0,93ย โ‚ฌ51.43%
2018-0,61ย โ‚ฌ159.26%
2017-0,24ย โ‚ฌ-3.57%
2016-0,25ย โ‚ฌ-37.78%
2015-0,39ย โ‚ฌ-33.82%
2014-0,60ย โ‚ฌ36%
2013-0,44ย โ‚ฌ11.11%
2012-0,39ย โ‚ฌ50%
2011-0,26ย โ‚ฌ-50%
2010-0,53ย โ‚ฌ-233.33%
20090,39ย โ‚ฌ-142.86%
2008-0,92ย โ‚ฌ-65%
2007-2,63ย โ‚ฌ
20050,87ย โ‚ฌ-108.03%
2004-10,80ย โ‚ฌ13203.07%
2003-0,08115ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
3,84ย โ‚ฌ-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-4,98ย โ‚ฌ 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,51ย โ‚ฌ 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
16,16ย โ‚ฌ-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,74ย โ‚ฌ 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA